April 15 Midday Market Review: GEM Index Opens High and Falls, Closing Down 0.23%; Innovative Drug Concepts Rally CollectivelyWallstreetcn·Apr 14 at 10:30 PM688166+3.49%000919+1.62%
Xinhua Pharmaceutical Wins NMPA Approval for New Electrolyte InjectionTip Ranks·Apr 7 at 06:23 AM512290+0.60%1595060.00%
China's pet prescription food welcomes a breakthrough playerWallstreetcn·Jan 12 at 06:16 PM600267+0.52%
HISUN: Has cumulatively spent CNY 56.9915 million to repurchase 0.51% of its sharesZhitong·Nov 3, 2025 at 02:43 AM600267+0.52%
On the morning of the second day of the National Conference in 2025: Shenghe Pharmaceutical, HISUN, and other pharmaceutical companies enter the venueZhitong·Oct 30, 2025 at 07:35 PMSNY+0.44%600267+0.52%
HISUN Pharmaceuticals and ShengZhao Pharmaceuticals jointly established a joint venture company to expand their international presence in the complex injectable drug fieldZhitong·Oct 30, 2025 at 12:52 AM600267+0.52%
HISUN: Plans to win the bid for national centralized drug procurementZhitong·Oct 29, 2025 at 04:26 AM600267+0.52%
HISUN: EU revokes the statement of non-compliance with GMP for Taizhou factoryZhitong·Oct 19, 2025 at 04:42 AM600267+0.52%
HISUN: 1,4-Butanedisulfonic acid adenosylmethionine has passed the US Self-GRAS certificationZhitong·Oct 9, 2025 at 03:40 AM600267+0.52%
HISUN disclosed the progress of its fourth share repurchase, with a total repurchase of nearly 51 millionZhitong·Oct 9, 2025 at 03:05 AM600267+0.52%
HISUN: Tacrolimus capsules have passed the consistency evaluation of quality and efficacy for generic drugsZhitong·Sep 29, 2025 at 02:40 AM600267+0.52%
HISUN introduces its first innovative small molecule conjugate drugZhitong·Sep 17, 2025 at 03:43 AM600267+0.52%
HISUN: Signed an exclusive product licensing and strategic cooperation agreement with Aixin DaweiZhitong·Sep 16, 2025 at 05:47 AM600267+0.52%
HISUN: Tigecycline raw materials obtained CEP certificationZhitong·Sep 12, 2025 at 04:28 AM600267+0.52%
